With over 5000 products available, we can supply over 95% of the most common reagents for assay development, manufacturing and validation. Monoclonal and polyclonal antibodies critical for immunoassay tests and research applications. Our in-house expertise supports manufacturing and custom processing of base matrix materials.

Medix Biochemica is a market-leading in vitro diagnostics raw material supplier with Finnish roots and global branches. We produce and supply high-quality antibodies, antigens and other critical IVD raw materials to enable our IVD customers to manufacture diagnostic tests and supporting materials all around the world.

发源于芬兰的全球化公司，几十年来我们专注服务于体外诊断行业，在此了解我们的历史、专长和对体外诊断行业的承诺。 Medix Biochemica是一家拥有芬兰背景的真正全球性公司，数十年 …

Medix Biochemica拥有各种体外诊断用抗体的开发工具，从小鼠杂交瘤到嵌合重组单抗。 我们的研发科学家Emilia Galli博士于2022年6月在阿姆斯特丹举行的 欧洲抗体工程与治疗学会议 上介绍了我们体外诊断用重组抗体生产的最新进展。

Medix Bichemica致力于为您提供所需要的各种资源，助力您加速研发，缩短体外诊断产品的上市时间。

2023年2月16日 · Medix Biochemica was established in Finland in 1985, and since then we have been manufacturing and supplying high-quality raw materials for the in vitro diagnostics (IVD) industry, as well as research and development institutes. Our vision is to become the first-choice raw material partner for the IVD industry.1,2. Did You Know?

We develop, produce and supply high-quality antibodies, antigens, and other critical raw material products to our IVD partners all around the world, enabling the delivery of accurate IVD tests to...

MedixMDx提供的不仅有各种高品质原料和即用型预混液，我们还拥有在体外诊断原料和试剂盒研发生产方面极具经验的专家、为您提供技术支持。 从概念设计到产品上市的每一步，我们设 …

在此，我们很高兴地宣布，从2023年4月1日起，这两个公司产品的品牌都将被整合为Medix Biochemica，其公司名称也将改为Medix Biochemica USA Inc. Effective April 1, 2023, the two companies will become one legal entity known as Medix Biochemica USA Inc.

该 Taq DNA聚合酶具有5' 到3' 核酸外切酶活性，基于适配体热启动配方，可防止错误扩增，具有快速启动功能 (也可提供基于抗体热启动配方的酶)。 该酶提供了更广泛的扩增应用场景，支持 …